Login
Toggle navigation
Videos
Categories
Trending
Teleborsa S.p.A. interviews Alessio Aceti, CEO of Sababa Security.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alessio Aceti is the CEO of Sababa Security.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
#CEOTalks featuring Romina Parquet, CEO of CIMC Wetrans in Argentina, discuss industry insights and developments with MetroGAS.
00:10:00
Portofino Resources: Advancing High-Grade Lithium Projects in Argentina's Salar de Rio Grande
00:10:00
How Three Key Industry Shifts Are Driving Success for Four High-Quality Holdings at Royce Investment Partners
00:10:00
Amarillo Gold: Advancing Brazilian Gold Projects with Confidence
00:10:00
Olsundsorv: Expanding Gold Exploration in Russia at One-to-One Mining Investment Conference
00:00:00
Jenny Sundqvist, CEO, InDex Pharmaceuticals Holding
00:10:00
mission is to partner with entrepreneurs solving big problems across enterprise|Andrew Perlman, Managing Partner,GreatPoint Ventures
00:10:00
"Dr. Dietmar Ley, CEO of Basler AG, shares insights on the company's growth trajectory and future outlook in an exclusive interview at the Deutsches Eigenkapitalforum."|The Basler AG management board is comprised of Dr. Dietmar Ley (CEO)
00:00:00
Stephen Stamp, CEO & CFO, Midatech Pharma P
00:10:00
Committed to delivering optimal solutions by leveraging their industry experience|Jakob Dock, Senior Director, Oracle Partners
00:10:00
Assessing SEB's Economic Shifts and Outlook | Johan Torgeby, CEO, SEB.
00:10:00
Jerry Kalogiratos: Regional Energy Partnerships | Gerasimos (Jerry) Kalogiratos - Director and CEO of Capital Product Partners L.P.